Translocator protein (TSPO)-targeting positron emission tomography (PET) imaging is currently mainly used for imaging neurodegenerative diseases [1] and brain gliomas [2] as TSPO is considered a biomarker of neuroinflammation and microglial activation. This evidence concerns the gene TSPO and neurodegenerative disease.